{"id":"W2563072979","doi":"10.1016/s1525-0016(16)33457-8","title":"649. Developing FGFR4 Chimeric Antigen Receptor CAR T Cell Therapy Against Rhabdomyosarcoma","year":2016,"lang":"en","type":"article","venue":"Molecular Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Fibroblast growth factor receptor 4; Immunohistochemistry; Molecular biology; Cancer research; Biology; Fusion protein; Antibody; Receptor; Fibroblast growth factor receptor; Recombinant DNA; Immunology; Fibroblast growth factor; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001388293,0.0003407164,0.00025067,0.0002568049,0.0001125245,0.0002126968,0.0001978421,0.0004203736,0.002375557],"category_scores_gemma":[0.00006918138,0.0001105279,0.0002850227,0.00008630191,0.0001167487,0.0001136389,0.0001316382,0.0003767517,0.001098928],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002362333,"about_ca_system_score_gemma":0.0002384614,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007270774,"about_ca_topic_score_gemma":0.001175831,"domain_scores_codex":[0.9999267,0.00001104119,0.000005111751,0.00001141973,0.00002102494,0.00002476193],"domain_scores_gemma":[0.9999757,0.000003486142,0.00000418727,0.000001901484,0.000007485096,0.000007212392],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001965257,0.0002514197,0.000449386,0.0001067946,0.00001994454,0.0001865213,0.00003155283,0.0003858902,0.9785455,0.0003275459,0.0007463307,0.01875255],"study_design_scores_gemma":[0.0005314629,0.007204466,0.005954479,0.00003476441,0.0001778242,0.001814658,0.00005015642,0.004492557,0.9354392,0.0001933174,0.0440917,0.00001536939],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9724255,0.004190552,0.008773698,0.0004114774,0.000163597,0.0004575929,0.0005954765,0.0003603975,0.01262168],"genre_scores_gemma":[0.9746731,0.003099199,0.007995214,0.0002391873,0.00003956269,0.0003374049,0.001666593,0.00003039684,0.01191939],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002375557,"threshold_uncertainty_score":0.007946968,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0269789725639087,"score_gpt":0.2925045110461414,"score_spread":0.2655255384822328,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}